HomeIMA • NASDAQ
ImageneBio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.36M | 15.25% |
Net income | -7.59M | -21.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.36M | -23.94% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.02M | — |
Total assets | 19.13M | — |
Total liabilities | 34.24M | — |
Total equity | -15.11M | — |
Shares outstanding | 11.18M | — |
Price to book | -19.42 | — |
Return on assets | -115.38% | — |
Return on capital | -421.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -7.59M | -21.19% |
Cash from operations | -11.90M | -99.25% |
Cash from investing | — | — |
Cash from financing | 13.02M | — |
Net change in cash | 1.10M | 118.19% |
Free cash flow | -10.28M | — |
Previous close
$8.35
Day range
$8.35 - $8.65
Year range
$7.95 - $23.18
Market cap
93.26M USD
Avg Volume
34.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Website
Employees
9
